France· FR:69985600
MACROGOL 4000 ZYDUS 4 g, poudre pour solution buvable en sachet
A macrogol 4000 product containing macrogol 4000, registered in France by ZYDUS FRANCE, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Macrogol 4000 is registered in 4 of 19 countries.
Countries holding a registration under ATC MACROGOL 4000 (macrogol 4000), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 2 of them publish a price we can compare per daily dose
Macrogol 4000 · ATC MACROGOL 4000
4 / 19 countries
- Franceprice
- Germany
- Spainprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MACROGOL 4000
- Manufacturer
- ZYDUS FRANCE
- Country
- France (FR)
- ATC code
- MACROGOL 4000
- ATC class
- MACROGOL 4000
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093027059220 sachet(s) papier aluminium polyéthylène de 4 gEUR 1.88
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Macrogol 4000 in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenCasenlax 4 g Pulver till oral lösning i dospåseCasen Recordati, S.L.
- CzechiaFORLAXMayoly Pharma France, Rueil-Malmaison
- NetherlandsForlax Junior 4 g, poeder voor drank in sachet 4 gMayoly Pharma France
- FinlandCasenlaxCasen Recordati, S.L.
- GermanyForlaxIpsen Consumer Healthcare
- SwitzerlandLaxipeg banane
- PolandForlax 10 gMAYOLY PHARMA FRANCE
- United KingdomDulcobalance 10g oral powder sachetsBoehringer Ingelheim Self-Medication Division
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Forlax, Macrogol 4000 Strides
- Belgium · Forlax, Forlax Junior
- Bulgaria · Касенлакс
- Cyprus · Macrogol 4000 Casen Recordati
- Czechia · Forlax
- Germany · Forlax, Laxatan
- Denmark · Casenlax, Macrogol 4000 Strides
- Estonia · Forlax, Proctolax
- Spain · Casenlax, Femlax
- Finland · Casenlax, Makrogoli Orion
- United Kingdom (Northern Ireland) · Dulcobalance, Peglax
- Greece · Cleenlax, Cleenlax Forte
- Ireland · Idrolax, Peglax
- Italy · Casenjunior, Casenlax
- Lithuania · Forlax, Macrogol 4000 Casen Recordati
- Luxembourg · Forlax, Forlax Junior
- Latvia · Forlax, Proctolax
- Netherlands · Forlax, Forlax Junior
- Norway · Casenlax, Golax
- Poland · Forlax, Macrogol Aurovitas
- Portugal · Casenlax, Forlax
- Romania · Forlax, Proctolax
- Sweden · Casenlax, Forlax
- Slovakia · Forlax, Laxatan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5e37e89-4b81-4c7b-a804-08c1053967b7 GET /v1/drugs/f5e37e89-4b81-4c7b-a804-08c1053967b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69985600",
"date_amm": "2023-03-01",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MACROGOL 4000",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about macrogol 4000.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.